NEW YORK (GenomeWeb News) – Myriad Genetics reported on Tuesday a 37 percent increase in fiscal year 2014 second quarter revenues compared to the year-ago period.

For the three months ended Dec. 31, 2013, the company brought in total revenues of $204.1 million, up from $149.1 million in the second quarter of 2013, and above analysts' consensus estimate of $176 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.